FFCP PHASE1:Mm9::chr12:114654516..114654525,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=18|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr12:114654516..114654525,-|id=chr12:114654516..114654525,-|ontology_enrichment_celltype=CL:0000553!3.67e-31!6;CL:0000556!3.67e-31!6;CL:0000050!7.87e-21!9;CL:0000414!4.61e-17!11;CL:0000839!1.90e-14!13;CL:0000763!9.56e-12!16;CL:0002027!9.09e-11!3;CL:0002006!9.09e-11!3;CL:0002024!9.09e-11!3;CL:0002031!1.31e-10!25;CL:0000049!6.85e-10!19;CL:0000945!6.23e-09!1;CL:0000236!6.23e-09!1;CL:0000826!6.23e-09!1;CL:0000988!3.14e-08!32;CL:0002032!3.14e-08!32;CL:0000037!3.14e-08!32;CL:0000566!3.14e-08!32;CL:0000837!3.14e-08!32|ontology_enrichment_celltype_v019_2=CL:0000945,8.39e-23,1;CL:0000236,8.39e-23,1;CL:0000826,8.39e-23,1;CL:0000553,1.58e-15,6;CL:0000556,1.58e-15,6;CL:0000050,1.01e-10,9;CL:0002031,1.05e-08,25;CL:0000839,9.70e-08,13;CL:0000988,5.58e-07,32;CL:0002032,5.58e-07,32;CL:0000037,5.58e-07,32;CL:0000837,5.58e-07,32|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002371!9.56e-12!16;UBERON:0000029!5.23e-09!1;UBERON:0001097!5.23e-09!1;UBERON:0003968!5.23e-09!1;UBERON:0008785!5.23e-09!1;UBERON:0001467!5.23e-09!1;UBERON:0001421!5.23e-09!1;UBERON:0001474!1.54e-08!22;UBERON:0004765!1.54e-08!22;UBERON:0001434!1.54e-08!22;UBERON:0000996!1.74e-08!1;UBERON:0002193!3.62e-07!48|ontology_enrichment_uberon_v019_2=UBERON:0000029,5.07e-23,1;UBERON:0001097,5.07e-23,1;UBERON:0003968,5.07e-23,1;UBERON:0001467,5.07e-23,1;UBERON:0002465,1.34e-08,3|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.666219523631325,0.607425802169478,0,1.89277299214943,3.83920414096069,0.84877930359606,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.01339127269284,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.58937883647172,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.248813941220186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.172684981865896,0.144649058581512,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.170870880797853,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.214368379079066,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr12:114654516..114654525,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=18 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr12:114654516..114654525,- | |||
|description=CAGE_peak_at_chr12:114654516..114654525,- | |||
|id=chr12:114654516..114654525,- | |||
|ontology_enrichment_celltype=CL:0000553!3.67e-31!6;CL:0000556!3.67e-31!6;CL:0000050!7.87e-21!9;CL:0000414!4.61e-17!11;CL:0000839!1.90e-14!13;CL:0000763!9.56e-12!16;CL:0002027!9.09e-11!3;CL:0002006!9.09e-11!3;CL:0002024!9.09e-11!3;CL:0002031!1.31e-10!25;CL:0000049!6.85e-10!19;CL:0000945!6.23e-09!1;CL:0000236!6.23e-09!1;CL:0000826!6.23e-09!1;CL:0000988!3.14e-08!32;CL:0002032!3.14e-08!32;CL:0000037!3.14e-08!32;CL:0000566!3.14e-08!32;CL:0000837!3.14e-08!32 | |||
|ontology_enrichment_celltype_v019_2=CL:0000945,8.39e-23,1;CL:0000236,8.39e-23,1;CL:0000826,8.39e-23,1;CL:0000553,1.58e-15,6;CL:0000556,1.58e-15,6;CL:0000050,1.01e-10,9;CL:0002031,1.05e-08,25;CL:0000839,9.70e-08,13;CL:0000988,5.58e-07,32;CL:0002032,5.58e-07,32;CL:0000037,5.58e-07,32;CL:0000837,5.58e-07,32 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002371!9.56e-12!16;UBERON:0000029!5.23e-09!1;UBERON:0001097!5.23e-09!1;UBERON:0003968!5.23e-09!1;UBERON:0008785!5.23e-09!1;UBERON:0001467!5.23e-09!1;UBERON:0001421!5.23e-09!1;UBERON:0001474!1.54e-08!22;UBERON:0004765!1.54e-08!22;UBERON:0001434!1.54e-08!22;UBERON:0000996!1.74e-08!1;UBERON:0002193!3.62e-07!48 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000029,5.07e-23,1;UBERON:0001097,5.07e-23,1;UBERON:0003968,5.07e-23,1;UBERON:0001467,5.07e-23,1;UBERON:0002465,1.34e-08,3 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.666219523631325,0.607425802169478,0,1.89277299214943,3.83920414096069,0.84877930359606,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.01339127269284,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.58937883647172,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.248813941220186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.172684981865896,0.144649058581512,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.170870880797853,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.214368379079066,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr12:114654516..114654525,- | |||
}} |
Latest revision as of 19:44, 4 August 2015
Short description: | p@chr12:114654516..114654525, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr12:114654516..114654525, - |
Coexpression cluster: | MCL_coexpression_mm9:18 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
lymphocyte of B lineage | 8.39e-23 | 1 |
B cell | 8.39e-23 | 1 |
pro-B cell | 8.39e-23 | 1 |
megakaryocyte progenitor cell | 1.58e-15 | 6 |
megakaryocyte | 1.58e-15 | 6 |
megakaryocyte-erythroid progenitor cell | 1.01e-10 | 9 |
hematopoietic lineage restricted progenitor cell | 1.05e-08 | 25 |
myeloid lineage restricted progenitor cell | 9.70e-08 | 13 |
hematopoietic cell | 5.58e-07 | 32 |
hematopoietic oligopotent progenitor cell | 5.58e-07 | 32 |
hematopoietic stem cell | 5.58e-07 | 32 |
hematopoietic multipotent progenitor cell | 5.58e-07 | 32 |
Ontology term | p-value | n |
---|---|---|
lymph node | 5.07e-23 | 1 |
axillary lymph node | 5.07e-23 | 1 |
peripheral lymph node | 5.07e-23 | 1 |
shoulder | 5.07e-23 | 1 |
lymphoid system | 1.34e-08 | 3 |